| Carli Crapps, NP | |
|
4436 Mangum Dr, Flowood, MS 39232-2113 | |
| (601) 586-7070 | |
| (601) 586-7071 |
| Full Name | Carli Crapps |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 4436 Mangum Dr, Flowood, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134523111 | NPI | - | NPPES |
| 02879887 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | R885870 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Vascular And Vein Associates, Llc | 2668863085 | 10 |
News Archive
Being born preterm goes hand in hand with an increased risk for neuro-cognitive deficits. Psychologists from the Ruhr-Universit-t Bochum and the University of Warwick, UK have investigated the relation between the duration of pregnancy and cognitive abilities under varying work load conditions.
A new study has found that particulate matter (PM) plays a role in providing surfaces for SARS-CoV-2 transmission and interaction, enabling fomite transmission through deposition.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
The human heart makes precious few new cells but manages to generate billions of life-sustaining beats as it grows old.
Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).
› Verified 7 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Being born preterm goes hand in hand with an increased risk for neuro-cognitive deficits. Psychologists from the Ruhr-Universit-t Bochum and the University of Warwick, UK have investigated the relation between the duration of pregnancy and cognitive abilities under varying work load conditions.
A new study has found that particulate matter (PM) plays a role in providing surfaces for SARS-CoV-2 transmission and interaction, enabling fomite transmission through deposition.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
The human heart makes precious few new cells but manages to generate billions of life-sustaining beats as it grows old.
Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).
› Verified 7 days ago
| Entity Name | Advanced Vascular And Vein Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275205809 PECOS PAC ID: 2668863085 Enrollment ID: O20211220000638 |
News Archive
Being born preterm goes hand in hand with an increased risk for neuro-cognitive deficits. Psychologists from the Ruhr-Universit-t Bochum and the University of Warwick, UK have investigated the relation between the duration of pregnancy and cognitive abilities under varying work load conditions.
A new study has found that particulate matter (PM) plays a role in providing surfaces for SARS-CoV-2 transmission and interaction, enabling fomite transmission through deposition.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
The human heart makes precious few new cells but manages to generate billions of life-sustaining beats as it grows old.
Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carli Crapps, NP 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5452 | Carli Crapps, NP 4436 Mangum Dr, Flowood, MS 39232-2113 Ph: (601) 586-7070 |
News Archive
Being born preterm goes hand in hand with an increased risk for neuro-cognitive deficits. Psychologists from the Ruhr-Universit-t Bochum and the University of Warwick, UK have investigated the relation between the duration of pregnancy and cognitive abilities under varying work load conditions.
A new study has found that particulate matter (PM) plays a role in providing surfaces for SARS-CoV-2 transmission and interaction, enabling fomite transmission through deposition.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
The human heart makes precious few new cells but manages to generate billions of life-sustaining beats as it grows old.
Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).
› Verified 7 days ago